During a survey of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae in Bulgaria in 2001-2002, three isolates from Sofia (two Escherichia coli, one Klebsiella pneumoniae) showed cefotaxime MICs that were decreased in the presence of clavulanate and were 2-8-fold higher than those of ceftazidime. Resistance was transferred to a sensitive recipient strain of E. coli. Both wild-type and transconjugant strains produced a cefotaxime-hydrolysing β -lactamase of pI 8.8. Sequencing of the PCR product obtained with oligonucleotide primers binding outside the coding region identified this β-lactamase as CTX-M-15. To our knowledge, this is the first report of CTX-M-15 in Bulgaria. © 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases.
CITATION STYLE
Markovska, R., Schneider, I., Keuleyan, E., & Bauernfeind, A. (2004). Extended-spectrum β-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria. Clinical Microbiology and Infection, 10(8), 752–755. https://doi.org/10.1111/j.1469-0691.2004.00929.x
Mendeley helps you to discover research relevant for your work.